Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Freedom M. Green"'
Autor:
Yifan Wu, Freedom M. Green, Stephen A. Shaw, Lauren J. Bonilla, Shannon E. Ronca, Maria Elena Bottazzi, Farrah Kheradmand, Jill E. Weatherhead
Publikováno v:
Genes and Diseases, Vol 11, Iss 4, Pp 101167- (2024)
Externí odkaz:
https://doaj.org/article/ec842f2a601947cb86ae5dac72f2658b
Autor:
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract AKS-452, a subunit vaccine comprising an Fc fusion of the ancestral wild-type (WT) SARS-CoV-2 virus spike protein receptor binding domain (SP/RBD), was evaluated without adjuvant in a single cohort, non-randomized, open-labelled phase II stu
Externí odkaz:
https://doaj.org/article/3e169ceb8cc4445682f02ab1847c3f9e
Autor:
Andrea R Delpero, Larry Karnes, Shannon E. Ronca, Shashikant Nagre, David G. Alleva, Sarah S Webb, Hanne Andersen Elyard, Allison I Jasa, Thomas M. Lancaster, JoAnn Yee, Sylaja Murikipudi, Vidhya Rao, Frans Sollie, Nishit J Shah, Freedom M Green, Melanie M Scully, Jeffrey R Haworth, Thillainaygam Sathiyaseelan, Emma K Greaves, Ramya Ragupathy, Jeffrey Klein, Todd C. Zion
Publikováno v:
Vaccine
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutra
Autor:
Hephzibah Nwanosike, Freedom M. Green, Kristy O. Murray, Jill E. Weatherhead, Shannon E. Ronca
Publikováno v:
Methods in Molecular Biology ISBN: 9781071627594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74309a1e3e017381e9f27e6fc04afebc
https://doi.org/10.1007/978-1-0716-2760-0_12
https://doi.org/10.1007/978-1-0716-2760-0_12
Autor:
Freedom M. Green, Shannon E. Ronca
Publikováno v:
Methods in Molecular Biology ISBN: 9781071627594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef88b9e4adba15adc2a3f8e365b04243
https://doi.org/10.1007/978-1-0716-2760-0_18
https://doi.org/10.1007/978-1-0716-2760-0_18
Autor:
Hephzibah, Nwanosike, Freedom M, Green, Kristy O, Murray, Jill E, Weatherhead, Shannon E, Ronca
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2585
West Nile virus (WNV) is one of the leading causes of arboviral encephalitis in the United States but is often underdiagnosed. Despite the wide breadth of WNV-induced clinical disease syndromes, many of the symptoms associated with WNV are nonspecifi
Autor:
Freedom M, Green, Shannon E, Ronca
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2585
West Nile virus (WNV) can cause severe and sometimes fatal disease, but we do not have treatments or therapeutics to manage these outcomes. Since its introduction to the USA in 1999, WNV has been handled in a biosafety level 3 laboratory to decrease
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
Autor:
Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
Publikováno v:
Vaccine
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTD
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTD
To address the coronavirus disease 2019 (COVID-19) pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recombinant subunit vaccine, AKS-452, is being developed comprising an Fc fusion protein of the SARS-